Literature DB >> 12191656

Cryptosporidiosis: epidemiology and impact.

Rebecca A Dillingham1, Aldo A Lima, Richard L Guerrant.   

Abstract

Cryptosporidium was first recognized in humans in 1976 and came to prominence in the 1980s and 1990s as a cause of severe diarrheal illness in patients with AIDS. Its hardy, chlorine-resistant oocysts, tiny size, low infectious dose, fully infectious development when shed and zoonotic potential make it a threat in drinking and recreational water, contaminated food, day care centers, hospitals, and in persons with exposure to animals or unsanitary conditions, with potentially huge, long-term impact in malnourished children, as reviewed herein.

Entities:  

Mesh:

Year:  2002        PMID: 12191656     DOI: 10.1016/s1286-4579(02)01630-1

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  68 in total

1.  Evaluation of rapid antigen point-of-care tests for detection of Giardia and Cryptosporidium species in human fecal specimens.

Authors:  Juliana Minak; Mamun Kabir; Iqbal Mahmud; Yue Liu; Lei Liu; Rashidul Haque; William A Petri
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  The state of research for AIDS-associated opportunistic infections and the importance of sustaining smaller research communities.

Authors:  Anthony P Sinai; Edna S Kaneshiro; Honorine Ward; Louis M Weiss; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2011-12-09

3.  Arginine decreases Cryptosporidium parvum infection in undernourished suckling mice involving nitric oxide synthase and arginase.

Authors:  Ibraim C Castro; Bruna B Oliveira; Jacek J Slowikowski; Bruna P Coutinho; Francisco Júlio W S Siqueira; Lourrany B Costa; Jesus Emmanuel Sevilleja; Camila A Almeida; Aldo A M Lima; Cirle A Warren; Reinaldo B Oriá; Richard L Guerrant
Journal:  Nutrition       Date:  2012-01-20       Impact factor: 4.008

Review 4.  Cryptosporidiosis: environmental, therapeutic, and preventive challenges.

Authors:  S Collinet-Adler; H D Ward
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

5.  Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh.

Authors:  Anoli J Borad; Geneve M Allison; David Wang; Sabeena Ahmed; Mohammad M Karim; Anne V Kane; Joy Moy; Patricia L Hibberd; Sitara Swarna Rao Ajjampur; Gagandeep Kang; Stephen B Calderwood; Edward T Ryan; Elena Naumova; Wasif A Khan; Honorine D Ward
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

6.  Presence of Cryptosporidium spp. and Giardia duodenalis in drinking water samples in the north of Portugal.

Authors:  André Almeida; Maria João Moreira; Sónia Soares; Maria de Lurdes Delgado; João Figueiredo; Elisabete Silva; António Castro; José Manuel Correida Da Cosa
Journal:  Korean J Parasitol       Date:  2010-03-18       Impact factor: 1.341

7.  Exploring novel strategies for AIDS protozoal pathogens: α-helix mimetics targeting a key allosteric protein-protein interaction in C. hominis TS-DHFR.

Authors:  W Edward Martucci; Johanna M Rodriguez; Melissa A Vargo; Matthew Marr; Andrew D Hamilton; Karen S Anderson
Journal:  Medchemcomm       Date:  2013-09       Impact factor: 3.597

8.  Rifaximin: recent advances in gastroenterology and hepatology.

Authors:  Gary R Lichtenstein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-06

9.  Integrated cryptosporidium assay to determine oocyst density, infectivity, and genotype for risk assessment of source and reuse water.

Authors:  Brendon King; Stella Fanok; Renae Phillips; Brooke Swaffer; Paul Monis
Journal:  Appl Environ Microbiol       Date:  2015-03-13       Impact factor: 4.792

10.  Antibodies fused to innate immune molecules reduce initiation of Cryptosporidium parvum infection in mice.

Authors:  Michael Imboden; Michael W Riggs; Deborah A Schaefer; E Jane Homan; Robert D Bremel
Journal:  Antimicrob Agents Chemother       Date:  2010-01-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.